NTRA

NASDAQ · Biotechnology

Natera Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$197.37

+2.85 (+1.47%)

As of Mar 25, 9:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 24 89%

Hold 3 11%

Sell 0 0%

Price Target

Analyst Price Target -27.6% upside

Low Target $88.14

Average Target $142.91

High Target $188.78

Current Price $197.37

Current
$197.37

Target
$142.91

$88.14 $142.91 avg $188.78

Scenario Analysis

Bear Case

$88.14

-55.3%

Low target

Base Case

$142.91

-27.6%

Avg target

Bull Case

$188.78

+-4.4%

High target

Risk/Reward

0.1x

Unfavorable

Price in Context

52-Week High

$256.36

-23.0% from high

52-Week Low

$125.38

+57.4% from low

50-Day SMA

$229.31

-13.9% vs SMA

200-Day SMA

$186.42

+5.9% vs SMA

RSI (14)

38.6

Neutral

Target vs 52W High

$142.91

-44.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%